Gilead seeks to develop products that represent advancements by offering enhanced modes of delivery, more convenient treatment regimens, improved resistance profiles, reduced side effects and greater efficacy. Through our own research and partnerships with universities, medical research institutions and global pharmaceutical leaders, Gilead is rapidly and efficiently making scientific and clinical advancements that raise the standard for new therapeutics that treat life-threatening diseases.


  • AmBisome®

    amphotericin b liposome for injection
    50 mg/vial

  • Atripla®

    efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg

  • Cayston®

    aztreonam for inhalation solution          
    75 mg/vial

  • Complera®

    emtricitabine 200 mg/rilpivirine 25 mg/tenofovir disoproxil fumarate 300 mg

  • Emtriva®

    emtricitabine 200 mg

  • Hepsera®

    adefovir dipivoxil 10 mg

  • Letairis®

    ambrisentan 5 mg and 10 mg

  • Lexiscan®

    regadenoson injection 0.4 mg

  • Macugen®

    pegaptanib sodium injection 0.3 mg

  • Ranexa®

    ranolazine 500 mg and 1000 mg

  • Sovaldi®

    sofosbuvir 400 mg

  • Stribild®

    elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg

  • Tamiflu®

    oseltamivir phosphate 75 mg

  • Truvada®

    emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg

  • Viread®

    tenofovir disoproxil fumarate 300 mg

  • Vistide®

    cidofovir injection

  • Atripla®

    efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg

  • Complera®

    emtricitabine 200 mg/rilpivirine 25 mg/tenofovir disoproxil fumarate 300 mg

  • Emtriva®

    emtricitabine 200 mg

  • Stribild®

    elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg

  • Truvada®

    emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg

  • Viread®

    tenofovir disoproxil fumarate 300 mg

  • Hepsera®

    adefovir dipivoxil 10 mg

  • Sovaldi®

    sofosbuvir 400 mg

  • Viread®

    tenofovir disoproxil fumarate 300 mg

  • Letairis®

    ambrisentan 5 mg and 10 mg

  • Lexiscan®

    regadenoson injection 0.4 mg

  • Ranexa®

    ranolazine 500 mg and 1000 mg

  • Cayston®

    aztreonam for inhalation solution          
    75 mg/vial

  • Tamiflu®

    oseltamivir phosphate 75 mg

  • AmBisome®

    amphotericin b liposome for injection
    50 mg/vial

  • Macugen®

    pegaptanib sodium injection 0.3 mg

  • Vistide®

    cidofovir injection